Scarica l'app Stockscreener
45.26
1.09%
0.49
Dopo l'orario di chiusura:
45.40
0.14
+0.31%
Prestige Consumer Healthcare Inc Borsa (PBH) Ultime notizie
Best Value Stocks to Buy for October 1st - Zacks Investment Research
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times
Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings? - Yahoo Finance
Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets - Yahoo Finance
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - Yahoo Finance
Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com India
Prestige Consumer Healthcare Inc. (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo Finance
A Look at Prestige Consumer Healthcare Inc (PBH) After 3.8% Decl - GuruFocus
Responsive Playbooks and the PBH Inflection - Stock Traders Daily
Prestige Consumer Healthcare stock gains ahead of Sidoti event - AD HOC NEWS
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 50% Upside Potential Amid Steady Revenue Growth - DirectorsTalk Interviews
Prestige Consumer Healthcare stock falls as analysts stay cautious - AD HOC NEWS
Prestige Consumer Healthcare stock falls after sharp drop toward 52-week low - AD HOC NEWS
Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.2% -- What GF Score of 65 Tells Investors - GuruFocus
Prestige Consumer Healthcare stock holds steady as investors focus on recent earnings trend - AD HOC NEWS
Trading Systems Reacting to (PBH) Volatility - Stock Traders Daily
PBH: Portfolio expansion and brand integration drive growth, with Clear Eyes recovery a key focus - TradingView
Prestige Consumer Healthcare at Barclays conference: growth via niche brands - Investing.com Canada
How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com - Investing.com India
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - The Manila Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Assessing a Promising 29.74% Potential Upside - DirectorsTalk Interviews
Is This the Right Time to Add PBH Stock to Your Portfolio? - TradingView
Precision Trading with Prestige Consumer Healthcare Inc. (PBH) Risk Zones - Stock Traders Daily
Prestige Consumer Healthcare stock holds steady as investors watch valuation and growth - AD HOC NEWS
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test - Financial Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring A 29% Upside Potential - DirectorsTalk Interviews
PBH Q2 2026 Earnings: EPS Beats Estimates by 10.01% as Stock Advances 2.46%Profit Guidance Range - dars.gov.et
PBH vs. SYK: Which Stock Is the Better Value Option? - Yahoo Finance
Tobe Cohen Named Chief Executive Officer of Hyland’s Consumer Health and Hello Bello Consumer Wellness - Yahoo Finance
Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential - DirectorsTalk Interviews
40,000 eye drop bottles recalled over potential contamination - Oman Observer
Nearly 40,000 eye drop bottles are recalled over potential contamination - The Seattle Times
40,000 bottles of eye drops across the US recalled over issues with sterility of product - inkl
Clear Eyes Maximum Itchy Eye Relief Recall: FDA Announces 39,060 Bottles RecalledNews and Statistics - IndexBox
Nearly 40,000 eye drops recalled nationwide over possible contamination - Fox Business
Great Lakes Advisors LLC Takes $2.98 Million Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Nearly 40,000 bottles of eye drops recalled nationwide over possible contamination - FOX 32 Chicago
Clear Eyes eye drops recalled over sterility concerns - qz.com
FDA announces nationwide recall of nearly 40,000 Clear Eyes eye-drop bottles over potential contamination - The Economic Times
Is Prestige Consumer Healthcare’s (PBH) Upgraded 2027 Outlook and Halted Buybacks Reframing Its Growth Story? - webull.com
Rice Hall James & Associates LLC Acquires Shares of 689,692 Prestige Consumer Healthcare Inc. $PBH - MarketBeat
FDA recalls over 39K bottles of CLEAR EYES Maximum Itchy Relief drops - Glance by Eyes On Eyecare
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript - AOL.com
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 31.96% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare (PBH) Holds Near $51.38 as Range-Bound Trading PersistsVolume Dry Up - vinanet.vn
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Prestige Consumer Healthcare Announces Operations Leadership Transition - The Globe and Mail
Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations - TradingView
1.15%
5.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):